Search Results - "Peredo, Inti"

Optimized protein extraction from cryopreserved brain tissue samples.

Authors: Ericsson, Christer Peredo, Inti Nistér, Monica

Source: Acta Oncologica. Jan2007, Vol. 46 Issue 1, p10-20. 11p. 5 Graphs.

Two-year survival of low-grade and high-grade glioma patients using data from the Swedish Cancer Registry.

Authors: Mathiesen, Tiit Peredo, Inti Lönn, Stefan

Source: Acta Neurochirurgica. Mar2011, Vol. 153 Issue 3, p467-471. 5p. 2 Charts, 1 Graph.

Activation of Neural and Pluripotent Stem Cell Signatures Correlates with Increased Malignancy in Human Glioma.

Authors: Holmberg, Johan Xiaobing He Peredo, Inti et al.

Source: PLoS ONE. 2011, Vol. 6 Issue 3, p1-10. 10p.

Valganciclovir in patients with glioblastoma.

Authors: Söderberg-Nauclér, Cecilia Peredo, Inti Stragliotto, Giuseppe

Source: New England Journal of Medicine. 11/21/2013, Vol. 369 Issue 21, p2066-2067. 2p.

Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival

Authors: Rahbar, Afsar Orrego, Abiel Peredo, Inti et al.

Source: Journal of Clinical Virology. May2013, Vol. 57 Issue 1, p36-42. 7p.

Proliferation, migration and differentiation of ependymal region neural progenitor cells in the brainstem after hypoglossal nerve avulsion.

Authors: Fagerlund, Michael Jaff, Nasren Danilov, Alexandre I. et al.

Source: Restorative Neurology & Neuroscience. 2011, Vol. 29 Issue 1, p47-59. 13p.

NY-ESO-1- and survivin-specific T-cell responses in the peripheral blood from patients with glioma.

Authors: Liu, Zhenjiang Poiret, Thomas Persson, Oscar et al.

Source: Cancer Immunology, Immunotherapy. Feb2018, Vol. 67 Issue 2, p237-246. 10p.

Increased Survival Using Delayed Gamma Knife Radiosurgery for Recurrent High-Grade Glioma: A Feasibility Study.

Authors: Dodoo, Ernest Huffmann, Beate Peredo, Inti et al.

Source: World Neurosurgery. Nov2014, Vol. 82 Issue 5, pe623-e632. 1p.

Human cytomegalovirus particles directly suppress CD4 T-lymphocyte activation and proliferation.

Authors: Fornara, Olesja Odeberg, Jenny Khan, Zahidul et al.

Source: Immunobiology. Aug2013, Vol. 218 Issue 8, p1034-1040. 7p.

Tumor-infiltrating lymphocytes (TILs) from patients with glioma.

Authors: Liu, Zhenjiang Meng, Qingda Bartek, Jiri et al.

Source: OncoImmunology. 2017, Vol. 6 Issue 2, pN.PAG-N.PAG. 1p.

Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients.

Authors: Rahbar, Afsar Cederarv, Madeleine Wolmer-Solberg, Nina et al.

Source: OncoImmunology. Feb2016, Vol. 5 Issue 2, p1-1. 1p.

Poor survival in glioblastoma patients is associated with early signs of immunosenescence in the CD4 T-cell compartment after surgery.

Authors: Fornara, Olesja Odeberg, Jenny Wolmer Solberg, Nina et al.

Source: OncoImmunology. Sep2015, Vol. 4 Issue 9, pN.PAG-N.PAG. 0p.

Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.

Authors: Rahbar, Afsar Solberg, Nina Wolmer Taher, Chato et al.

Source: OncoImmunology. Feb2015, Vol. 4 Issue 2, pN.PAG-N.PAG. 0p.

Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir.

Authors: Söderberg-Naucler C Peredo I Rahbar A et al.

Source: International journal of cancer [Int J Cancer] 2014 Jul 01; Vol. 135 (1), pp. 248-9. Date of Electronic Publication: 2014 Jan 06.

Publication Type: Letter; Comment

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.

Authors: Stragliotto G Rahbar A Solberg NW et al.

Source: International journal of cancer [Int J Cancer] 2013 Sep 01; Vol. 133 (5), pp. 1204-13. Date of Electronic Publication: 2013 Mar 13.

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma.

Authors: Valentini D Rao M Meng Q et al.

Source: Oncotarget [Oncotarget] 2018 Dec 04; Vol. 9 (95), pp. 36817. Date of Electronic Publication: 2018 Dec 04 (Print Publication: 2018).

Publication Type: Journal Article; Published Erratum

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

Cytokine Networks and Survivin Peptide-Specific Cellular Immune Responses Predict Improved Survival in Patients With Glioblastoma Multiforme.

Authors: Zhenjiang L Rao M Luo X et al.

Source: EBioMedicine [EBioMedicine] 2018 Jul; Vol. 33, pp. 49-56. Date of Electronic Publication: 2018 Jun 29.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma.

Authors: Valentini D Rao M Meng Q et al.

Source: Oncotarget [Oncotarget] 2018 Apr 13; Vol. 9 (28), pp. 19469-19480. Date of Electronic Publication: 2018 Apr 13 (Print Publication: 2018).

Publication Type: Journal Article

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE

Mesothelin-specific Immune Responses Predict Survival of Patients With Brain Metastasis.

Authors: Zhenjiang L Rao M Luo X et al.

Source: EBioMedicine [EBioMedicine] 2017 Sep; Vol. 23, pp. 20-24. Date of Electronic Publication: 2017 Aug 30.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE

Mesothelin as a novel biomarker and immunotherapeutic target in human glioblastoma.

Authors: Liu Z Rao M Poiret T et al.

Source: Oncotarget [Oncotarget] 2017 Aug 16; Vol. 8 (46), pp. 80208-80222. Date of Electronic Publication: 2017 Aug 16 (Print Publication: 2017).

Publication Type: Journal Article

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE